Global Health Technology Assessment (HTA)

DRG Abacus have extensive experience in developing successful and fully supported evidence dossiers for submission to Health Technology Assessment (HTA) bodies across the globe. Having developed in full or contributed to over 150 National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) HTA submissions since 2010, we are a trusted and reliable partner for our clients, with an above industry approval success rate.

In particular, DRG Abacus are experts when it comes to HTA submissions across the European Union. After commissioning us to write an initial HTA submission, it is not uncommon that our clients then instruct us to proceed with preparing equivalent submissions for other HTA governing bodies.

The availability of specialist skill sets at DRG Abacus allows us to assign customised, multidisciplinary project teams including modelling, statistical analysis and writing expertise, in order to manage your HTA submission from initial development to successful outcome. Our experience extends across a wide range of disease areas, including submissions for rare conditions and medical devices.

We are part of Clarivate, a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

Our Company
© DRG Abacus 2021